NCT02121054
Completed
Not Applicable
Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
Young-Hak Kim, MD, PhD1 site in 1 country1,527 target enrollmentOctober 19, 2013
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiovascular Diseases
- Sponsor
- Young-Hak Kim, MD, PhD
- Enrollment
- 1527
- Locations
- 1
- Primary Endpoint
- Major adverse event
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the prognosis of patients with resistance to antiplatelet agent and develop tailored treatment model for patients with coronary artery disease.
Investigators
Young-Hak Kim, MD, PhD
MD, PhD
Asan Medical Center
Eligibility Criteria
Inclusion Criteria
- •Patients with coronary artery disease
- •Patients with peripheral artery disease
Exclusion Criteria
- •Renal dysfunction
- •Hepatic dysfunction
- •Major surgery planned within 1 year
- •Malignant tumor
- •History of gastrointestinal bleeding
- •low or high platelet count
Outcomes
Primary Outcomes
Major adverse event
Time Frame: 2 year
Major adverse event : overall mortality, cardiovascular mortality, target vessel revascularization
Secondary Outcomes
- Biomarker(2 year)
Study Sites (1)
Loading locations...
Similar Trials
Temporarily Not Available
Not Applicable
Clopidogrel Resistance and the Possibility of Its AffectionCoronary Artery DiseaseNCT00839345Charles University, Czech Republic
Completed
Not Applicable
Antiplatelet Resistance Research in Patients With Peripheral Arterial RevascularizationVascular DiseasesNCT03953547Fondation Hôpital Saint-Joseph88
Unknown
Not Applicable
Platelet Function in Patients With an Acute Coronary SyndromeAcute Coronary Syndrome (ACS)NCT01992484Medical University of Vienna1,000
Not yet recruiting
Not Applicable
Assessment of Antiplatelet resistance like aspirin and clopidogrel in patients with Ischemic stroke using Thromboelastogram Platelet MappingCTRI/2023/07/055555Gleneagles Global Hospital
Completed
Not Applicable
Antiplatelet Drug Resistances and Ischemic EventsSymptomatic AtherothrombosisNCT00501423Pierre Fontana771